Omeros VP sells 10,906 shares after option exercise
OMEROS CORP (OMER) reports that its VP, Finance & CAO, David J. Borges, exercised employee stock options and sold the resulting common shares.
Rhea-AI Filing Summary
OMEROS CORP (OMER) reports that its VP, Finance & CAO, David J. Borges, exercised employee stock options and sold the resulting common shares. On August 21 and 24, 2026, he exercised options to acquire a total of 10,906 shares of common stock at exercise prices of $2.94 and $3.93 per share, then sold 10,906 shares of common stock in open-market transactions at prices of $18.95 and $19.10 per share.
The sales were made pursuant to a previously established Rule 10b5-1 trading plan adopted on February 10, 2026. The exercised options relate to grants that vest over 48 equal monthly installments starting April 1, 2022 and April 1, 2023, with expiration dates in 2032 and 2033. All transactions are reported as direct ownership; post-transaction share holdings are not specified in this filing.
Positive
- None.
Negative
- None.
Insider Trade Summary 10b5-1
Exercise and Sale: 10,906 shares ($169K approx. pre-tax spread)
Exercise and Sale
8 txns
Insider
Borges David J.
Role
VP, Finance & CAO
Sold
10,906 shs ($207K)
Approx. gross sale proceeds
$207K
Approx. exercise cost
$38K
Approx. pre-tax spread
$169K
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Option (Right to Buy) F3 | 906 | $0.00 | $0.00 |
| Exercise | Common Stock | 906 | $2.94 | $3K |
| Sale | Common Stock F1 | 906 | $19.10 | $17K |
| Exercise | Stock Option (Right to Buy) F2 | 5,906 | $0.00 | $0.00 |
| Exercise | Stock Option (Right to Buy) F3 | 4,094 | $0.00 | $0.00 |
| Exercise | Common Stock | 5,906 | $3.93 | $23K |
| Exercise | Common Stock | 4,094 | $2.94 | $12K |
| Sale | Common Stock F1 | 10,000 | $18.95 | $190K |
Holdings After Transaction:
Stock Option (Right to Buy) — 29,094 contracts (Direct);
Common Stock — 0 shares (Direct)
Footnotes (3)
- F1. Open market sale pursuant to a previously established Rule 10b5-1 trading plan adopted by the reporting person on February 10, 2026. The trading schedule, including sale periods and the number of shares to be sold, was established at the time of the trading plan's adoption in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.
- F2. This option vests and becomes exercisable over 48 equal monthly installments, with a vesting commencement date of April 1, 2022. Installments vest and become exercisable on each monthly anniversary thereafter.
- F3. This option vests and becomes exercisable over 48 equal monthly installments, with a vesting commencement date of April 1, 2023. Installments vest and become exercisable on each monthly anniversary thereafter.
Key Figures
Shares sold: 10,906 shares
Shares acquired via option exercise: 10,906 shares
Sale price August 21, 2026: $18.95 per share
+5 more
8 metrics
Shares sold
10,906 shares
Total OMER common shares sold on August 21 and 24, 2026
Shares acquired via option exercise
10,906 shares
Total OMER common shares acquired through option exercises reported
Sale price August 21, 2026
$18.95 per share
Open-market sale of 10,000 OMER shares
Sale price August 24, 2026
$19.10 per share
Open-market sale of 906 OMER shares
Option exercise price
$3.93 per share
Stock option (Right to Buy) for 5,906 underlying OMER shares expiring 2032-09-20
Option exercise price
$2.94 per share
Stock options (Right to Buy) for 5,000 underlying OMER shares expiring 2033-09-21
Vesting schedule length
48 equal monthly installments
Employee stock options vesting from April 1, 2022 and April 1, 2023
Rule 10b5-1 plan adoption date
February 10, 2026
Date David J. Borges adopted the trading plan governing the reported sales
Key Terms
Rule 10b5-1 trading plan, Stock Option (Right to Buy), Exercise or conversion of derivative security, vesting commencement date, +1 more
5 terms
Rule 10b5-1 trading plan regulatory
"Open market sale pursuant to a previously established Rule 10b5-1 trading plan"
A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.
Stock Option (Right to Buy) financial
"security_title: Stock Option (Right to Buy)"
Exercise or conversion of derivative security financial
"transaction_code_description: Exercise or conversion of derivative security"
vesting commencement date financial
"with a vesting commencement date of April 1, 2022"
The vesting commencement date is the starting point when an employee begins earning ownership rights to their promised benefits, such as stock options or retirement contributions. Think of it like the day a savings account is opened—only after this date do the benefits start to grow and become fully available over time. It matters to investors because it marks when the clock begins ticking toward full ownership, affecting the timing and value of these benefits.
Common Stock financial
"underlying_security_title: Common Stock"
Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.
FAQ
What insider transactions did OMER (OMEROS CORP) report for David J. Borges?
OMER reported that VP, Finance & CAO, David J. Borges exercised options for 10,906 shares of common stock and sold 10,906 shares in open-market transactions on August 21 and 24, 2026.
What stock options did David J. Borges exercise in this OMER Form 4?
He exercised stock options covering 10,906 shares of OMER common stock, including options with exercise prices of $3.93 per share (5,906 shares) and $2.94 per share (a total of 5,000 shares), with expiration dates in 2032 and 2033.
How do the exercised OMER options for David J. Borges vest?
The options exercised by David J. Borges vest over 48 equal monthly installments. One grant has a vesting commencement date of April 1, 2022, and another of April 1, 2023, with installments vesting on each monthly anniversary thereafter.
AI-generated analysis. How Rhea-AI works. Not financial advice.
